| Bioactivity | BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells)[1]. |
| CAS | 2362-25-6 |
| Formula | C20H18N4O2 |
| Molar Mass | 346.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Peng H, et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3693-9. |
BCR-ABL-IN-11
CAS: 2362-25-6 F: C20H18N4O2 W: 346.38
BCR-ABL-IN-11 (Compound 2) is aBCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous le
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.